Pulmonary neuroendocrine tumors. Current review

被引:0
|
作者
Meyer, Hans-Jonas [1 ]
Frille, Armin [2 ]
Tiepolt, Solveig [3 ]
Denecke, Timm [1 ]
机构
[1] Univ Klinikum Leipzig, Klin & Poliklin Diagnost & Intervent Radiol, Liebigstr 20, D-04103 Leipzig, Germany
[2] Univ Klinikum Leipzig, Klin & Poliklin Onkol Gastroenterol Hepatol & Pneu, Leipzig, Germany
[3] Univ Klinikum Leipzig, Klin & Poliklin Nukl Med, Leipzig, Germany
来源
RADIOLOGIE | 2024年 / 64卷 / 07期
关键词
Neuroendocrine neoplasia; Carcinoid tumor; Computed tomography; Positron emission tomography; Radiomics; DIAGNOSIS; LUNG;
D O I
10.1007/s00117-024-01319-8
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Clinical issue: Neuroendocrine neoplasms of the lung are a heterogenous tumor group. The pathological classification comprises diffuse idiopathic pulmonary neuroendocrine cell hyperplasia, classic neuroendocrine tumors, and neuroendocrine carcinoma. Classic neuroendocrine tumors include typical and atypical carcinoid tumors. Diagnostic work-up: Imaging plays an important role in diagnosis and can help in identifying the tumor biology. Overall, this tumor group is rare, comprising less than 2% of all thoracic tumors. Practical recommendations: In the current review, the various tumors are presented and important aspects regarding pathological classification, imaging modalities, and treatment are described.
引用
收藏
页码:546 / 552
页数:7
相关论文
共 50 条
  • [41] Pancreatic neuroendocrine tumors. A uncommon diagnosis - frequently unrecognized!
    Schmidt, W.
    GASTROENTEROLOGE, 2006, 1 (01): : 43 - 50
  • [42] Radiological Imaging of Gastro-Entero-Pancreatic Neuroendocrine Tumors. The Review of Current Literature Emphasizing the Diagnostic Value of Chosen Imaging Methods
    Poltorak-Szymczak, Gabriela
    Budlewski, Tadeusz
    Furmanek, Mariusz Ireneusz
    Wierzba, Waldemar
    Sklinda, Katarzyna
    Walecki, Jerzy
    Mruk, Bartosz
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [43] Expression of neuronal/neuroendocrine markers in choroid plexus tumors.
    Gyure, KA
    Morrison, AL
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2000, 59 (05): : 420 - 420
  • [44] The expression of versican and its role in pancreatic neuroendocrine tumors.
    Sun, Zhao
    Gao, Heli
    Gu, Junjie
    Cheng, Yuejuan
    Chen, Yuanjia
    Bai, Chunmei
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [45] Prognostic factors in patients with neuroendocrine gastroenteropancreatic (GEP) tumors.
    Sprenger, A
    Wied, M
    Mueller, HH
    Rickenbach, A
    Mathias, W
    Funk, R
    Arnold, R
    GASTROENTEROLOGY, 2000, 118 (04) : A514 - A514
  • [46] Pognostic significance of chromogranin A in small pancreatic neuroendocrine tumors.
    Raoof, Mustafa
    Jutric, Zeljka
    Melstrom, Laleh Golkar
    Warner, Susanne
    Woo, Yanghee
    Fong, Yuman
    Singh, Gagandeep
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [47] Analysis of survival and prognostic factors of thymic neuroendocrine tumors.
    Mao, Yinggang
    Ma, Yihui
    Li, Xiangke
    Yang, Minjie
    Song, Lijie
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [48] A miRNA signature Predicts Grading of Pancreatic Neuroendocrine Tumors.
    Saller, James
    Magliocco, Anthony
    Coppola, Domenico
    LABORATORY INVESTIGATION, 2019, 99
  • [49] Octreotide use in patients with metastatic pancreatic neuroendocrine tumors.
    Cheema, A.
    Weber, J.
    Kvols, L. K.
    Strosberg, J. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [50] Significance of lymph node metastasis in pancreatic neuroendocrine tumors.
    Taki, Katsunobu
    Hashimoto, Daisuke
    Ozaki, Nobuyuki
    Tomiyasu, Shinjiro
    Inoue, Risa
    Yamamura, Kensuke
    Kitano, Yuuki
    Arima, Kota
    Kaida, Takayoshi
    Higashi, Takaaki
    Imai, Katsunori
    Chikamoto, Akira
    Beppu, Toru
    Takamori, Hiroshi
    Hirota, Masahiko
    Baba, Hideo
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)